Read Time:18 Second
The Exchange had sought clarification from Vilin Bio Med Limited for the quarter ended 30-Sep-2024 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Consolidated Financial Results not submitted The response of the Company is enclosed. |SUBJECT: Reply to Clarification- Financial results
